CLL Society in the News

CLL Society in the News

Medical and general news reports frequently feature CLL Society as a trusted information source and an authoritative voice of CLL patients’ concerns. When CLL Society surfaces in the news, we share it here.


April 22, 2022

Founder Retirement Announcement

This month marks the end of an era at CLL Society. Patty Koffman, our Co-Founder and Communications Director, will begin enjoying a much-deserved retirement in May, following the launch of our new and improved website. We celebrate her many contributions to the CLL patient community and look forward to Patty’s continued engagement as a volunteer advisor as CLL Society moves into the next chapter of our organization’s evolution.

Read the Tribute to Patty Koffman

February 28, 2022

FDA Authorizes Revisions to Evusheld Dosing

If we have learned anything during this pandemic, we have learned that much of our knowledge quickly becomes obsolete. This is because it’s constantly being swept up in the flood tide of new viral mutation and scientific research.

The pandemic has indeed humbled many, including me.

On 2/24/2022, the FDA announced it recommends doubling the dose of Evusheld to protect the immunocompromised better, including those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) against all variants of SARS-COV-2, the virus that causes COVID-19.

Read more.



When appropriate, CLL Society will post updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.